Steven G Arless

From Wikipedia, the free encyclopedia
Steven G Arless
Steve Arless Head Shot.png
Born (1949-07-23) July 23, 1949 (age 73)
Alma materMcGill University (BSc 1971)
Concordia University (MBA 2008)
Occupation(s)Medical Technology Entrepreneur, Adjunct Professor
TitleProfessor of Practice, McGill University
Co-Founder, Soundbite Medical Solutions Inc.
Co-Founder & CEO, ViTAA Medical Solutions Inc

Steven G Arless is a Canadian entrepreneur in the biomedical technology industry.[1] He directed and developed several medical device companies treating cardiovascular disease from inception through major financing and public stock offering, advancing new medical devices from R&D to commercialization and global sales, including CryoCath Technologies, CardioInsight and Resonant Medical.[2][3] He has served as CEO for a number of companies, most notably CryoCath Technologies (sold to Medtronic Inc. for $400 million CAD), Resonant Medical (sold to Elekta AB for $30 million), and CardioInsight (also sold to Medtronic for $100 million USD).

Early life and education[edit]

Arless was born in Montreal, Quebec on July 23, 1949. His father, an accountant, and his mother were immigrants to Canada from Lebanon.[4] Arless studied Chemistry and Engineering at McGill University, graduating with a BSc. in 1971.[1] Arless also completed his MBA at the John Molson School of Business at Concordia University in Montréal in 2008.[1]


Arless is an angel investor in medical technology and is involved in mentorship and teaching of graduate students at McGill University and Concordia University and McGill University where he is a Professor of Practice.[1]

In 1971, Arless worked with Smith & Nephew, a British medical equipment company for 17 years and served as president for five years.[4] He was CEO of the North American operations from 1986 to 1990.[4]

In 1996, Arless became CEO of CryoSurge founded in 1995 and changed the name to CryoCath Technologies inc., in 1997, a company specializing in a cryoablation treatment for heart arrhythmia.[5] Arless served as president and CEO of CryoCath from its inception until 2006, when he resigned.[6]

Arless relocated to Cleveland, Ohio in 2009 to become CEO of CardioInsight, a company marketing and advancing research in cardiovascular technology.[7][6] Arless stepped down from his position at CardioInsight in 2012.[8]

Arless co-founded medical device company, Soundbite Medical Solutions, which fabricated wire devices to treat occlusions caused by coronary and peripheral artery disease with shockwaves.[9] Arless stepped down as CEO in 2017.[10]

As of early 2018, Arless has been serving as MedTech Entrepreneur-in-Residence at Centech, a Montreal-based technology accelerator that strives to create new sustainable high tech business startups.[11]

In late 2019, Arless co-founded and took the position as CEO of ViTAA Medical Solutions, a healthcare AI company specializing in 3D mapping of patients with aortic aneurysms that provide surgeons with clinical intelligence to guide therapy.[12]


Arless was awarded the Ernst & Young Entrepreneur of the Year award in 2005 for Health Sciences.[13]


  1. ^ a b c d "Steve Arless, one of Canada's leading medical device entrepreneurs joins McGill's Department of Surgery". McGill Faculty of Medicine Electronic Newsletter. December 16, 2016. Retrieved October 23, 2017.
  2. ^ McEwen, Colin (January 20, 2011). "Q & A: Steve Arless brings stellar biomed reputation to Cleveland". Freshwater Cleveland. Retrieved October 23, 2017.
  3. ^ Mathre, Ryan (June 19, 2015). "Medtronic Announces Acquisition of CardioInsight Technologies, Developer of Non-Invasive Cardiac Mapping System". Medtronic Newsroom. Retrieved October 23, 2017.
  4. ^ a b c Phillips, Scott (February 4, 2016). "Want to Be a Medical Device Entrepreneur?". MedTech Intelligence. Retrieved October 23, 2017.
  5. ^ Bigelow, Bruce (January 12, 2009). "Medtronic To Pick Up Ablation Frontiers for $225 Million Upfront". Xconomy.
  6. ^ a b Vanac, Mary (March 16, 2010). "CardioInsight CEO Steve Arless on the importance of being early". Mass Device.
  7. ^ Conroy, John (July 1, 2010). "The MX Q&A: Steve Arless Takes IP Matters to Heart".
  8. ^ "CardioInsight Completes First Commercial Product Installation of its ECVUE Cardiac Mapping System". Diagnostic and Interventional Cardiology | DAIC. 2012-02-24. Retrieved 2017-10-23.
  9. ^ "Our Company – Soundbite medical". Retrieved 2017-10-23.
  10. ^ "SoundBite announces new CEO – Soundbite medical". Retrieved 2017-10-23.
  11. ^ "Acceleration of MedTech startups | ÉTS Montréal". Retrieved 2020-08-20.
  12. ^ "ViTAA Medical Solutions". ViTAA Medical Solutions. Retrieved 2020-08-20.
  13. ^ "Hall of Fame - EY Entrepreneur Of The Year". Retrieved 2017-10-23.